Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,560 | -7,049 | -8,770 | -5,217 | -2,681 |
| Depreciation Amortization | 140 | 17 | 4 | 3 | 2 |
| Accounts payable and accrued liabilities | -29 | 421 | 485 | 512 | 358 |
| Other Working Capital | -1 | 799 | 1,090 | 723 | 216 |
| Other Operating Activity | 3,871 | 2,895 | 1,231 | 502 | 317 |
| Operating Cash Flow | $-7,579 | $-2,917 | $-5,960 | $-3,477 | $-1,788 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,987 | -22,414 | N/A | 0 | N/A |
| PPE Investments | -5 | -1 | -3 | -3 | -3 |
| Investing Cash Flow | $-24,992 | $-22,415 | $-3 | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 12,735 | 13,471 | 53,370 | 14,963 | 14,963 |
| Financing Cash Flow | $12,735 | $13,471 | $53,370 | $14,963 | $14,963 |
| Beginning Cash Position | 51,615 | 51,615 | 4,200 | 4,207 | 4,207 |
| End Cash Position | 31,779 | 39,754 | 51,610 | 15,690 | 17,379 |
| Net Cash Flow | $-19,836 | $-11,861 | $47,400 | $11,483 | $13,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,579 | -2,917 | -5,960 | -3,477 | -1,788 |
| Capital Expenditure | -5 | -1 | -3 | -3 | -3 |
| Free Cash Flow | -7,584 | -2,918 | -5,963 | -3,480 | -1,791 |